Brokerages expect Phibro Animal Health Corp (NASDAQ:PAHC) to post $0.43 earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have provided estimates for Phibro Animal Health’s earnings. Phibro Animal Health posted earnings per share of $0.46 during the same quarter last year, which indicates a negative year over year growth rate of 6.5%. The company is expected to report its next quarterly earnings results after the market closes on Monday, May 6th.

On average, analysts expect that Phibro Animal Health will report full year earnings of $1.68 per share for the current year, with EPS estimates ranging from $1.66 to $1.70. For the next fiscal year, analysts anticipate that the company will report earnings of $1.77 per share, with EPS estimates ranging from $1.76 to $1.80. Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side analysts that cover Phibro Animal Health.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings data on Wednesday, February 6th. The company reported $0.41 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.43 by ($0.02). Phibro Animal Health had a net margin of 8.69% and a return on equity of 36.37%. The company had revenue of $218.20 million during the quarter, compared to analysts’ expectations of $211.59 million. During the same quarter in the prior year, the company earned $0.44 earnings per share. The firm’s revenue was up 6.0% compared to the same quarter last year.

PAHC has been the topic of several recent analyst reports. Zacks Investment Research upgraded Phibro Animal Health from a “sell” rating to a “hold” rating in a research report on Tuesday, January 8th. BidaskClub upgraded Phibro Animal Health from a “strong sell” rating to a “sell” rating in a research report on Tuesday, December 18th. Finally, ValuEngine upgraded Phibro Animal Health from a “sell” rating to a “hold” rating in a research report on Thursday, March 21st. Two analysts have rated the stock with a sell rating and four have given a hold rating to the company. The stock has a consensus rating of “Hold” and an average price target of $43.50.

Shares of NASDAQ:PAHC traded up $0.03 on Wednesday, hitting $33.50. The company had a trading volume of 83,770 shares, compared to its average volume of 139,868. The company has a quick ratio of 1.83, a current ratio of 3.25 and a debt-to-equity ratio of 1.52. Phibro Animal Health has a 52-week low of $28.28 and a 52-week high of $54.62. The company has a market capitalization of $1.35 billion, a P/E ratio of 19.25, a P/E/G ratio of 3.60 and a beta of 0.62.

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Wednesday, March 6th were given a dividend of $0.12 per share. The ex-dividend date was Tuesday, March 5th. This represents a $0.48 annualized dividend and a yield of 1.43%. Phibro Animal Health’s dividend payout ratio (DPR) is presently 27.59%.

In related news, VP Daniel M. Bendheim sold 2,500 shares of the stock in a transaction dated Wednesday, January 16th. The stock was sold at an average price of $32.40, for a total transaction of $81,000.00. Following the transaction, the vice president now directly owns 2,500 shares in the company, valued at $81,000. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Dean J. Warras sold 21,560 shares of the stock in a transaction dated Tuesday, January 15th. The stock was sold at an average price of $31.81, for a total value of $685,823.60. Following the transaction, the insider now owns 21,560 shares in the company, valued at $685,823.60. The disclosure for this sale can be found here. Insiders have sold 41,450 shares of company stock worth $1,319,822 over the last quarter. 50.29% of the stock is currently owned by company insiders.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in PAHC. Northern Trust Corp raised its holdings in shares of Phibro Animal Health by 8.0% in the 4th quarter. Northern Trust Corp now owns 452,913 shares of the company’s stock worth $14,566,000 after purchasing an additional 33,656 shares during the period. Vanguard Group Inc raised its holdings in shares of Phibro Animal Health by 3.3% in the 3rd quarter. Vanguard Group Inc now owns 2,074,840 shares of the company’s stock worth $89,011,000 after purchasing an additional 66,676 shares during the period. New York State Common Retirement Fund raised its holdings in shares of Phibro Animal Health by 12.8% in the 4th quarter. New York State Common Retirement Fund now owns 52,379 shares of the company’s stock worth $1,685,000 after purchasing an additional 5,947 shares during the period. Confluence Investment Management LLC raised its holdings in shares of Phibro Animal Health by 70.3% in the 4th quarter. Confluence Investment Management LLC now owns 113,980 shares of the company’s stock worth $3,665,000 after purchasing an additional 47,051 shares during the period. Finally, Rhumbline Advisers raised its holdings in shares of Phibro Animal Health by 19.9% in the 4th quarter. Rhumbline Advisers now owns 58,359 shares of the company’s stock worth $1,877,000 after purchasing an additional 9,699 shares during the period. Hedge funds and other institutional investors own 49.97% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.

Featured Article: Short Selling Stocks and Day Traders

Get a free copy of the Zacks research report on Phibro Animal Health (PAHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.